Entrada Therapeutics shares owned by Natixis
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Natixis
from 13F filings
Historical chart of Natixis investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Natixis
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $433k | 31k | 13.88 |
| 2023-09-30 | $505k | 31k | 16.18 |
| 2023-06-30 | $468k | 31k | 15.00 |
| 2023-03-31 | $444k | 31k | 14.25 |
| 2022-12-31 | $350k | 26k | 13.37 |